Buller, Richard External Entity

Publications

Sort by

Selected publications

  • A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer.  Gynecologic Oncology2003 Academic Article GET IT
    Times cited: 62

Other